Lorazepam
Discover related
4 sources
🧬 Receptor activity
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| GABA-A receptor alpha-1/beta-3/gamma-2 (GABRA1) | Positive allosteric modulator | 8.456 IC50 | DRUGCENTRAL | TargetGABA-A receptor alpha-1/beta-3/gamma-2 (GABRA1) ActionPositive allosteric modulator Affinity8.456 IC50 SourceDRUGCENTRAL |
| Fatty acid-binding protein, liver (Fabp1) | — | 4.89 Ki | DRUGCENTRAL | TargetFatty acid-binding protein, liver (Fabp1) Action— Affinity4.89 Ki SourceDRUGCENTRAL |
External links
PubChem 3958 ↗CAS 846-49-1 ↗ChEBI CHEBI:6539 ↗ChEMBL CHEMBL580 ↗KEGG D00365 ↗DrugBank DB00186 ↗NIH ↗NIH ↗ChemSpider ↗ChEBI/ChEMBL ↗Guide to Pharmacology ↗NIH ↗NIH ↗NIH ↗NIH ↗DrugBank ↗ChEBI/ChEMBL ↗CAS 110032-65-0 ↗CAS 84344-15-0 ↗PsychonautWiki ↗Erowid ↗Experience reports (PiHKAL) ↗Experience reports (TiHKAL) ↗
Source: DrugCentral — Lorazepam ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.